Rambam Health Care Campus ( Site 1907)

Haifa 3109601

1 studies enrolling now · 2 studies all time

What they study most

Cervical Cancer, Classical Hodgkin Lymphoma

Studies at this site

• A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22) — Recruiting now
• Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) — Completed